Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
417.43
+3.45 (0.83%)
At close: May 7, 2025, 4:00 PM
416.41
-1.02 (-0.24%)
After-hours: May 7, 2025, 5:58 PM EDT
Elevance Health Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Elevance Health stock have an average target of 519.76, with a low estimate of 405.4 and a high estimate of 631. The average target predicts an increase of 24.51% from the current stock price of 417.43.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elevance Health stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 9 | 9 | 9 | 9 | 8 | 8 |
| Hold | 1 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $478 | Buy | Reiterates | $478 | +14.51% | Apr 23, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $518 | Strong Buy | Reiterates | $518 | +24.09% | Apr 23, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $485 | Buy | Reiterates | $485 | +16.19% | Apr 23, 2025 |
| Barclays | Barclays | Buy Maintains $512 → $522 | Buy | Maintains | $512 → $522 | +25.05% | Apr 23, 2025 |
| Baird | Baird | Buy → Hold Downgrades $625 → $529 | Buy → Hold | Downgrades | $625 → $529 | +26.73% | Apr 15, 2025 |
Financial Forecast
Revenue This Year
196.36B
from 176.81B
Increased by 11.06%
Revenue Next Year
210.43B
from 196.36B
Increased by 7.16%
EPS This Year
34.56
from 25.68
Increased by 34.58%
EPS Next Year
39.51
from 34.56
Increased by 14.32%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 213.9B | 231.4B | 252.3B | |
| Avg | 196.4B | 210.4B | 228.3B | |
| Low | 186.2B | 199.0B | 213.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 21.0% | 17.8% | 19.9% | |
| Avg | 11.1% | 7.2% | 8.5% | |
| Low | 5.3% | 1.4% | 1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.33 | 43.68 | 50.66 | ||
| Avg | 34.56 | 39.51 | 45.98 | ||
| Low | 30.32 | 36.20 | 41.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 41.5% | 26.4% | 28.2% | ||
| Avg | 34.6% | 14.3% | 16.4% | ||
| Low | 18.1% | 4.7% | 6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.